世界の左心耳閉鎖装置市場2020-2024

◆英語タイトル:Global Left Atrial Appendage Closure Market 2020-2024
◆商品コード:IRTNTR44439
◆発行会社(リサーチ会社):Technavio
◆発行日:2020年9月5日
◆ページ数:約120
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:ヨーロッパ、北米、アジア太平洋、その他の国
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥270,000見積依頼/購入/質問フォーム
Five User(5名様閲覧用)USD3,000 ⇒換算¥324,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥432,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はTechnavio社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Technavio社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本調査レポートでは、左心耳閉鎖装置の世界市場を調査・分析し、エグゼクティブサマリー、市場状況、市場規模、ファイブフォース分析、製品別(心外膜LAA閉鎖装置、心内膜LAA閉鎖装置)分析、エンドユーザー別分析、顧客状況、地域別状況、企業状況、企業分析などの項目を掲載しています。
・エグゼクティブサマリー
・市場状況
・市場規模
・ファイブフォース分析
・左心耳閉鎖装置の世界市場規模:製品別(心外膜LAA閉鎖装置、心内膜LAA閉鎖装置)
・左心耳閉鎖装置の世界市場規模:エンドユーザー別
・顧客状況
・地域別状況
・企業状況
・企業分析
【レポートの概要】

Global Left Atrial Appendage Closure Market 2020-2024
Technavio has been monitoring the left atrial appendage closure market and it is poised to grow by USD 1.64 bn during 2020-2024, progressing at a CAGR of 30% during the forecast period. Our reports on left atrial appendage closure market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the increasing incidences of atrial fibrillation and potential long-term cost-effectiveness associated with the use of LAA closure devices. In addition, increasing incidences of atrial fibrillation is anticipated to boost the growth of the market as well.

The left atrial appendage closure market analysis includes the product segment and geographical landscapes.
Technavio’s left atrial appendage closure market is segmented as below:

By Product
• Epicardial LAA closure device
• Endocardial LAA closure device

By Geographical Landscapes
• Europe
• North America
• APAC
• ROW

This study identifies the growing product approvals fueling market growth as one of the prime reasons driving the left atrial appendage closure market growth during the next few years.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our left atrial appendage closure market covers the following areas:
• Left atrial appendage closure market sizing
• Left atrial appendage closure market forecast
• Left atrial appendage closure market industry analysis

Technavio’s robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading left atrial appendage closure market vendors that include Abbott Laboratories, Aegis Medical Group, Append Medical, AtriCure Inc., Boston Scientific Corp., Cardia Inc., Carestream Health Inc., Johnson & Johnson, Lifetech Scientific (Shenzhen) Co. Ltd., and Occlutech International AB. Also, the left atrial appendage closure market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors. For further information on this report, please visit – https://www.technavio.com/report/left-atrial-appendage-closure-market-industry-analysis
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research – both primary and secondary. Technavio’s market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.

【レポートの目次】

• Executive Summary
o Market Overview
• Market Landscape
o Market ecosystem
o Value chain analysis
• Market Sizing
o Market definition
o Market segment analysis
o Market size 2019
o Market outlook: Forecast for 2019 – 2024
• Five Forces Analysis
o Five Forces Summary
o Bargaining power of buyers
o Bargaining power of suppliers
o Threat of new entrants
o Threat of substitutes
o Threat of rivalry
o Market condition
• Market Segmentation by Product
o Market segments
o Comparison by Product
o Epicardial LAA closure device – Market size and forecast 2019-2024
o Endocardial LAA closure device – Market size and forecast 2019-2024
o Market opportunity by Product
• Market Segmentation by End-user
• Customer landscape
• Geographic Landscape
o Geographic segmentation
o Geographic comparison
o Europe – Market size and forecast 2019-2024
o North America – Market size and forecast 2019-2024
o APAC – Market size and forecast 2019-2024
o ROW – Market size and forecast 2019-2024
o Key leading countries
o Market opportunity by geography
o Volume drivers – Demand led growth
o Volume drivers – External factors
o Market challenges
o Market trends
• Vendor Landscape
o Vendor landscape
o Landscape disruption
• Vendor Analysis
o Vendors covered
o Market positioning of vendors
o Abbott Laboratories
o Aegis Medical Group
o Append Medical
o AtriCure Inc.
o Boston Scientific Corp.
o Cardia Inc.
o Carestream Health Inc.
o Johnson & Johnson
o Lifetech Scientific (Shenzhen) Co. Ltd.
o Occlutech International AB
• Appendix
o Scope of the report
o Currency conversion rates for US$
o Research methodology
o List of abbreviations
Exhibit
• 1: Key Finding 1
• 2: Key Finding 2
• 3: Key Finding 3
• 4: Key Finding 5
• 5: Key Finding 6
• 6: Key Finding 7
• 7: Key Finding 8
• 8: Parent market
• 9: Market characteristics
• 10: Offerings of vendors included in the market definition
• 11: Market segments
• 12: Global – Market size and forecast 2019 – 2024 ($ million)
• 13: Global market: Year-over-year growth 2019 – 2024 (%)
• 14: Five forces analysis 2019 & 2024
• 15: Bargaining power of buyers
• 16: Bargaining power of suppliers
• 17: Threat of new entrants
• 18: Threat of substitutes
• 19: Threat of rivalry
• 20: Market condition – Five forces 2019
• 21: Product – Market share 2019-2024 (%)
• 22: Comparison by Product
• 23: Epicardial LAA closure device – Market size and forecast 2019-2024 ($ million)
• 24: Epicardial LAA closure device – Year-over-year growth 2019-2024 (%)
• 25: Endocardial LAA closure device – Market size and forecast 2019-2024 ($ million)
• 26: Endocardial LAA closure device – Year-over-year growth 2019-2024 (%)
• 27: Market opportunity by Product
• 28: Customer landscape
• 29: Market share by geography 2019-2024 (%)
• 30: Geographic comparison
• 31: Europe – Market size and forecast 2019-2024 ($ million)
• 32: Europe – Year-over-year growth 2019-2024 (%)
• 33: North America – Market size and forecast 2019-2024 ($ million)
• 34: North America – Year-over-year growth 2019-2024 (%)
• 35: APAC – Market size and forecast 2019-2024 ($ million)
• 36: APAC – Year-over-year growth 2019-2024 (%)
• 37: ROW – Market size and forecast 2019-2024 ($ million)
• 38: ROW – Year-over-year growth 2019-2024 (%)
• 39: Key leading countries
• 40: Market opportunity by geography ($ million)
• 41: Impact of drivers and challenges
• 42: Vendor landscape
• 43: Landscape disruption
• 44: Industry risks
• 45: Vendors covered
• 46: Market positioning of vendors
• 47: Abbott Laboratories – Overview
• 48: Abbott Laboratories – Business segments
• 49: Abbott Laboratories – Key offerings
• 50: Abbott Laboratories – Key customers
• 51: Abbott Laboratories – Segment focus
• 52: Aegis Medical Group – Overview
• 53: Aegis Medical Group – Product and service
• 54: Aegis Medical Group – Key offerings
• 55: Aegis Medical Group – Key customers
• 56: Aegis Medical Group – Segment focus
• 57: Append Medical – Overview
• 58: Append Medical – Product and service
• 59: Append Medical – Key offerings
• 60: Append Medical – Key customers
• 61: Append Medical – Segment focus
• 62: AtriCure Inc. – Overview
• 63: AtriCure Inc. – Business segments
• 64: AtriCure Inc. – Key offerings
• 65: AtriCure Inc. – Key customers
• 66: AtriCure Inc. – Segment focus
• 67: Boston Scientific Corp. – Overview
• 68: Boston Scientific Corp. – Business segments
• 69: Boston Scientific Corp. – Key offerings
• 70: Boston Scientific Corp. – Key customers
• 71: Boston Scientific Corp. – Segment focus
• 72: Cardia Inc. – Overview
• 73: Cardia Inc. – Product and service
• 74: Cardia Inc. – Key offerings
• 75: Cardia Inc. – Key customers
• 76: Cardia Inc. – Segment focus
• 77: Carestream Health Inc. – Overview
• 78: Carestream Health Inc. – Product and service
• 79: Carestream Health Inc. – Key offerings
• 80: Carestream Health Inc. – Key customers
• 81: Carestream Health Inc. – Segment focus
• 82: Johnson & Johnson – Overview
• 83: Johnson & Johnson – Business segments
• 84: Johnson & Johnson – Key offerings
• 85: Johnson & Johnson – Key customers
• 86: Johnson & Johnson – Segment focus
• 87: Lifetech Scientific (Shenzhen) Co. Ltd. – Overview
• 88: Lifetech Scientific (Shenzhen) Co. Ltd. – Business segments
• 89: Lifetech Scientific (Shenzhen) Co. Ltd. – Key offerings
• 90: Lifetech Scientific (Shenzhen) Co. Ltd. – Key customers
• 91: Lifetech Scientific (Shenzhen) Co. Ltd. – Segment focus
• 92: Occlutech International AB – Overview
• 93: Occlutech International AB – Product and service
• 94: Occlutech International AB – Key offerings
• 95: Occlutech International AB – Key customers
• 96: Occlutech International AB – Segment focus
• 97: Currency conversion rates for US$
• 98: Research Methodology
• 99: Validation techniques employed for market sizing
• 100: Information sources
• 101: List of abbreviations



【掲載企業】

Abbott Laboratories, Aegis Medical Group, Append Medical, AtriCure Inc., Boston Scientific Corp., Cardia Inc., Carestream Health Inc., Johnson & Johnson, Lifetech Scientific (Shenzhen) Co. Ltd., Occlutech International AB

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[世界の左心耳閉鎖装置市場2020-2024]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆